StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was -232.0%, against -137.6% the year before. The highest annual figure on record is -79.6% in fiscal 2023.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-232.0%−94.5
FY2024Dec 31, 2024-137.6%−58.0
FY2023Dec 31, 2023-79.6%+15.6
FY2022Dec 31, 2022-95.1%+26.4
FY2021Dec 31, 2021-121.5%+197.4
FY2020Dec 31, 2020-318.9%–

More CASI Pharmaceuticals figures

See a number that looks wrong?